Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
United Therapeutics Corp (UTHR)  
$243.27 4.59 (1.85%) as of 4:30 Wed 3/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 47,262,000
Market Cap: 11.50(B)
Last Volume: 648,210 Avg Vol: 416,479
52 Week Range: $205.19 - $256.94
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   United Therapeutics is a biotechnology company. Through its subsidiary, Lung Biotechnology PBC, Co. is focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Co. markets and sells the following commercial therapies to treat pulmonary arterial hypertension: Remodulin® (treprostinil) Injection; Tyvaso® (treprostinil) Inhalation Solution; Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, for the treatment of high-risk neuroblastoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 259,895 293,900 539,157 1,546,278
Total Sell Value $61,562,609 $69,425,851 $124,913,742 $377,791,812
Total People Sold 4 6 6 10
Total Sell Transactions 24 32 68 222
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 4949
  Page 1 of 198  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-26 4 AS $244.67 $3,724,939 D/D (15,000) 130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-26 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-25 4 AS $239.60 $3,650,401 D/D (15,000) 130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-25 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-22 4 AS $234.62 $3,555,823 D/D (15,000) 130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-22 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-21 4 AS $234.38 $3,545,158 D/D (15,000) 130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-21 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-03-21 4 AS $234.11 $1,418,726 D/D (6,000) 36,710 0%     
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-03-21 4 OE $117.76 $706,560 D/D 6,000 42,710     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-20 4 AS $234.33 $3,539,273 D/D (15,000) 130 0%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-20 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-19 4 AS $233.25 $3,548,922 D/D (15,000) 130 -1%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-19 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-18 4 AS $230.59 $3,513,552 D/D (15,000) 130 2%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-18 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-15 4 AS $235.63 $3,552,595 D/D (15,000) 130 1%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-15 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-14 4 AS $236.74 $3,567,243 D/D (15,000) 130 -0%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-14 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-13 4 AS $240.69 $3,641,949 D/D (15,000) 130 -1%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-13 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Olian Judy D.   –       •      –    2024-03-12 4 S $247.15 $1,241,006 D/D (5,000) 7,305 1%     
   Olian Judy D.   –       •      –    2024-03-12 4 OE $175.43 $877,150 D/D 5,000 12,305     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-12 4 AS $247.20 $3,719,247 D/D (15,000) 130 -4%     

  4949 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 198
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed